For research use only. Not for therapeutic Use.
MBM-55 (Cat.No:I018789) is a novel compound with promising therapeutic potential. It is being investigated for its role in modulating specific biological pathways involved in various diseases, including cancer and inflammatory disorders. Preliminary studies have shown that MBM-55 exhibits potent inhibitory activity against targeted molecular targets, making it a potential candidate for future drug development.
Catalog Number | I018789 |
CAS Number | 2083622-09-5 |
Molecular Formula | C₂₈H₂₇FN₆O₂ |
Purity | ≥95% |
Target | Apoptosis |
Reference | [1]. Xi JB, et al. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities. Eur J Med Chem. 2017 Jan 27;126:1083-1106. |